跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RSV-F
首页
药物
RSV-F
RSV-F
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
RSV F PROTEIN MUTANTS
EP 3393512 B1
申请人: PFIZER
优先权: 2015
CN
EP
US
WO
14 件公开
PREFUSION RSV F PROTEINS AND THEIR USE
EP 4421177 A2
申请人: US HEALTH
优先权: 2013
CN
EP
US
WO
13 件公开
US 9738689 B2
申请人: US HEALTH
优先权: 2014
US
3 件公开
RECOMBINANT HUMAN/BOVINE PARAINFLUENZA VIRUS 3 (B/HPIV3) EXPRESSING A CHIMERIC RSV/BPIV3 F PROTEIN AND USES THEREOF
EP 3247388 B1
申请人: US HEALTH
优先权: 2015
CN
EP
US
WO
12 件公开
RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME
EP 4218799 A1
申请人: GLAXOSMITHKLINE BIOLOGICALS SA
优先权: 2009
CN
EP
US
11 件公开
Modified RSV F proteins and methods of their use
US 8715692 B2
申请人: PUSHKO PETER
优先权: 2008
CN
US
11 件公开
US 11446374 B2
申请人: NOVAVAX INC
优先权: 2019
US
CONFORMATIONALLY STABILIZED RSV PRE-FUSION F PROTEINS
EP 3664836 A4
申请人: CALDER BIOSCIENCES INC
优先权: 2017
CN
EP
US
WO
10 件公开
EP 3024483 B1
申请人: CALDER BIOSCIENCES INC
优先权: 2013
EP
US
WO
9 件公开
IMMUNOGLOBULIN SINGLE VARIABLE DOMAIN ANTIBODY AGAINST RSV PREFUSION F PROTEIN
EP 3313432 B1
申请人: VIB VZW
优先权: 2015
CN
EP
US
WO
7 件公开
EP 3124042 A1
申请人: VIB VZW
优先权: 2015
EP
VACCINE AGAINST RSV COMPRISING MODIFIED F POLYPEPTIDE
EP 3821906 A1
申请人: JANSSEN VACCINES & PREVENTION BV
优先权: 2015
CN
EP
US
6 件公开
Substitutions-modified prefusion RSV F proteins and their use
US 11174292 B2
申请人: US HEALTH
优先权: 2016
CN
US
6 件公开
Stabilized soluble pre-fusion RSV F proteins
US 11155583 B2
申请人: JANSSEN VACCINES & PREVENTION BV
优先权: 2016
CN
EP
US
5 件公开
第 1 / 9 页
上一页
下一页
药物
反馈